Department of Radiology
Found 8 results
Filters: Author is McCloskey, Jaclyn E  [Clear All Filters]
2023
Yang Y, Yang H, Alcaina Y, Puc J, Birt A, Vedvyas Y, Gallagher M, Alla S, Riascos MCristina, McCloskey JE et al..  2023.  Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models.. Nat Commun. 14(1):2068.
2022
Alcaina Y, Yang Y, Vedvyas Y, McCloskey JE, Jin MM.  2022.  SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity.. Sci Rep. 12(1):20932.
2021
Yang Y, McCloskey JE, Yang H, Puc J, Alcaina Y, Vedvyas Y, Gallegos AAGomez, Ortiz-Sánchez E, de Stanchina E, Min IM et al..  2021.  Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.. Cancer Immunol Res. 9(10):1158-1174.
2020
Jung M, Yang Y, McCloskey JE, Zaman M, Vedvyas Y, Zhang X, Stefanova D, Gray KD, Min IM, Zarnegar R et al..  2020.  Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer.. Mol Ther Oncolytics. 18:587-601.
Gray KD, McCloskey JE, Vedvyas Y, Kalloo OR, Eshaky SEl, Yang Y, Shevlin E, Zaman M, Ullmann TM, Liang H et al..  2020.  PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.. Clin Cancer Res. 26(22):6003-6016.
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, van Basien K, Gaudet I et al..  2020.  Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 10(1):12733.
2019
Guo H, Kommidi H, Vedvyas Y, McCloskey JE, Zhang W, Chen N, Nurili F, Wu AP, Sayman HB, Akin O et al..  2019.  A Fluorescent, [F]-Positron-Emitting Agent for Imaging Prostate-Specific Membrane Antigen Allows Genetic Reporting in Adoptively Transferred, Genetically Modified Cells.. ACS Chem Biol. 14(7):1449-1459.
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, Van Besien K, Gaudet I et al..  2019.  Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 9(1):10634.